Anti-Human ITGA4+ITGB7 Recombinant Antibody (TAB-H75) (CAT#: TAB-H75)

Recombinant Humanized (from mouse) antibody to Human ITGA4+ITGB7. It is a monoclonal antibody for the treatment of ulcerative colitis and Crohn's disease.It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name vedolizumab.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Modalities:
  • Tested Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Anti-alpha 4 beta 7 Antibody (TAB-H75) in ELISA

Figure 1 Anti-alpha 4 beta 7 Antibody (TAB-H75) in ELISA

ELISA analysis of TAB-H75 was performed by coating with Human alpha 4 beta 7 Protein.

DB

Figure 2 Anti-alpha 4 beta 7 Antibody (TAB-H75) in Dot Blot

Figure 2 Anti-alpha 4 beta 7 Antibody (TAB-H75) in Dot Blot

Dot Blot analysis of TAB-H75 was performed by coating with Human alpha 4 beta 7 Protein.


Specifications

  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG1 - kappa
  • Specificity
  • ITGA4_ITGB7(integrin alpha4 (CD49d)_beta7, integrin alpha4_beta7, integrin α4β7, lymphocyte Peyer s patch adhesion molecule 1, LPAM-1) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • FC, IP, ELISA, Neut, FuncS, IF, WB
  • MW
  • 146.8 kDa
  • Related Disease
  • Ulcerative colitis (UC)

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.

Applications

  • Application Notes
  • The ITGA4+ITGB7 antibody has been reported in applications of FC, IF, Inhib, Agonist, H&E staining, IHC.

Target

  • Alternative Names
  • vedolizumab;vedolizumab;943609-66-3;MLN0002;MLN02;LDP02;ITGA4;ITGB7;Integrin α4β7;CD49d/β7

Related Resources

  • Biosimilar Overview
Please refer to Vedolizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Vedolizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "ITGA4 and ITGB7"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products ADCC Enhanced Antibody Products
CAT Product Name Application Type
TAB-H02 Anti-Human ITGA4+ITGB7 Recombinant Antibody (TAB-H02) IP, IF, FuncS, FC, Neut, ELISA, WB IgG2 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-H75. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-H75, RRID: AB_3112046)

Copy citation

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare